Research Reports

Summary

UBS Group's 31 March 2026 Pillar 3 Report discloses a USD 2.1bn increase in CET1 capital to USD 73.3bn, a USD 10.2bn rise in available TLAC to USD 197.6bn, and new regulatory capital impacts totaling USD 22bn for UBS AG standalone due to Swiss Basel III amendments and proposed foreign subsidiary deductions.

Key takeaways

CET1 capital increased by USD 2.1bn to USD 73.3bn in Q1 2026, driven by USD 3.8bn operating profit before tax, partially offset by USD 0.9bn dividend accruals and other outflows — supporting capital strength but reflecting ongoing payout pressure.

Available TLAC rose USD 10.2bn to USD 197.6bn, fueled by USD 3.7bn AT1 issuance and USD 9.0bn senior unsecured debt issuances, enhancing loss-absorbing capacity ahead of regulatory deadlines.

Swiss regulatory amendments — effective 2027–2029 — are expected to require USD 22bn incremental CET1 capital at UBS AG standalone level, including USD 20bn from full deduction of foreign subsidiary investments, posing significant future capital planning implications.

UBS repurchased USD 0.9bn of shares in Q1 2026 and remains on track to repurchase USD 3bn by end-July 2026, conditional on maintaining a ~14% year-end CET1 ratio and parliamentary deliberations on foreign subsidiary treatment.

Liquidity coverage ratio declined 4.8 percentage points to 177.8%, still well above FINMA’s requirement, while net stable funding ratio improved to 116.9%, indicating continued structural liquidity resilience despite higher net outflows.

Full analysis

This Pillar 3 Report conveys materially elevated regulatory capital requirements for UBS AG standalone, with USD 22bn of incremental CET1 capital needed under newly finalized Swiss rules — USD 2bn from revised treatment of capitalized software and prudential valuation adjustments (effective 2027–2029), and USD 20bn from the proposed full deduction of foreign subsidiary investments, phased in over seven years starting 2027. These measures compound the USD 15bn capital uplift already required post-Credit Suisse acquisition, bringing total incremental CET1 needs to ~USD 37bn. While UBS Group’s CET1 capital rose to USD 73.3bn and TLAC to USD 197.6bn in Q1 2026 — supported by strong operating profit before tax of USD 3.8bn and new AT1 and senior debt issuances — the forward-looking capital burden is substantial and contingent on unresolved parliamentary action. The share repurchase program remains active (USD 0.9bn executed, USD 3bn targeted by end-July), but explicitly conditioned on sustaining a ~14% CET1 ratio and clarity on foreign subsidiary treatment — introducing near-term execution risk. Liquidity metrics remain robust (LCR 177.8%, NSFR 116.9%), though the LCR decline reflects elevated deposit outflows, signaling potential funding volatility. Collectively, this report signals intensifying capital headwinds that will shape UBS’s capital allocation, M&A flexibility, and dividend sustainability through 2027–2030.